Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385418
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-04-17
Brief Title:
Fluorouracil Treatment Via Colon for Colorectal Cancer
Sponsor:
The Second Hospital of Nanjing Medical University
Organization:
The Second Hospital of Nanjing Medical University
Study Overview
Official Title:
Fluorouracil Treatment Via Colon for Colorectal Cancer an Exploratory Study
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Fluorouracil 5-FU is a commonly used drug for colorectal cancer CRC Thermosensitive hydrogel presents a promising carrier for 5-FU to address challenges encountered with traditional administration methods We propose an integrated approach utilizing colonic transendoscopic enteral tubing to cover the entire colon flexibly coupled with a thermo-sensitive gel to enhance the adhesion of 5-FU This clinical trial aims to assess the feasibility safety and efficacy of this approach for treating CRC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None